The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Plasma Interleukin-18 Levels in Patients With Psychiatric Disorders
Abstract
There are an increasing number of reports on an association between the alteration of circulating cytokine levels and pathophysiology of psychiatric disorders. Plasma concentrations of interleukin (IL)-18 were measured in 13 nonmedicated patients with psychiatric disorders. There was a significant elevation of IL-18 levels in patients with major depression (n = 8) and panic disorder (n = 5), compared with normal controls. The mean IL-18 value of our psychiatric patients was comparable with that of various somatic disorders reported. We suggest that the elevation of plasma IL-18 levels reflects the increased production and release of IL-18 in the central nervous system under stressful settings. We propose that the measurement of IL-18 plasma levels may provide a useful index for the involvement of immune system in psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this scenario, IL-18 serum levels were significantly elevated [156].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [156]
Citations
Cites
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784 · cited 1×
“A large body of literature is now emerging that indicates interactions between the central nervous system and the immune system and the involvement of specific cytokines in these complex interactions (1,2).”
BackgroundMaes, M., Lin, A.-H., Delmeire, L., Van Gastel, A., Kenis, G., De Jongh, R., & Bosmans, E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00131-0 · Cited by 387
Indicators of immune activation in major depression
Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., & Wiktorowicz, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02783-7 · Cited by 384
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · cited 1×
“In particular, some cases of schizophrenia have been reported to be associated with autoimmune response and viral infection (3,4), and major depression has been modulated by inflammatory cytokines (5,6).”
BackgroundInterleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Cerebrospinal Cytokine Levels in Patients with Acute Depression
Levine, J., Barak, Y., Chengappa, K. N. R., Rapoport, A., Rebey, M., & Barak, V. (1999) · Neuropsychobiology · doi:10.1159/000026615 · Cited by 354
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Capuron, L., Ravaud, A., & Dantzer, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2143 · Cited by 294
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
Ganguli, R., Yang, Z., Shurin, G., Chengappa, K. N. R., Brar, J. S., Gubbi, A. V., & Rabin, B. S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90042-6 · Cited by 222
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
“…et al., 2014; Leo et al., 2006; Lehto et al., 2010; Lehto et al., 2010; Lee and Kim, 2006; Lee et al., 2009; Kubera et al., 2000; Kokai et al., 2002; Kling et al., 2007; Kim et al., 2002; Maes et al., 1990; Miller et al., 2005; Mikova et al., 2001; Merendino et al., 2002; Marques-Deak et al.,…”
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568
Alcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J. A., Fernández-Rodríguez, A., & Cordero, M. D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.017 · Cited by 443
NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings
Kaufmann, F. N., Costa, A. P., Ghisleni, G., Diaz, A. P., Rodrigues, A. L. S., Peluffo, H., & Kaster, M. P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.002 · Cited by 370
“Clinical studies have revealed significantly higher plasma levels of IL-18 in patients with MDD (Kang et al., 2016; Kokai et al., 2002; Merendino et al., 2002), patients with post-stroke depressive (Bossù et al., 2009) and patients with depressive symptoms after kidney transplantation (Saharaei…”
Metadata
- Authors
- Kokai, M., Kashiwamura, S.-I., Okamura, H., Ohara, K., & Morita, Y.
- Affiliations
- Hyogo Medical University (JP)
- Corresponding author
- Kokai, Masahiro
- Ohara, Kazuyuki
- Morita, Yoshio
- ORCID
- Okamura, Haruki
- Venue
- Journal of Immunotherapy
- Published
- 2002-03
- Volume
- 25
- Pages
- S68-S71
- ISSN
- 1524-9557 (ISSN-L)
- OpenAlex
- W2335543403
- Cited by
- 67
- References
- 20
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 5 · 2017: 2 · 2016: 5 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Immunotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- IL-18, plasma cytokines, mental illness, major depressive disorder, panic disorder, cytokines, central nervous system, stress
- MeSH terms
- Adult, Mental Disorders, Depressive Disorder, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Probability, Prognosis, Reference Values, Sampling Studies, Sensitivity and Specificity, Biomarkers, Case-Control Studies, Panic Disorder, Interleukin-18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma Interleukin-18 Levels in Patients With Psychiatric Disorders. https://app.cochat.ai/papers/10.1097/00002371-200203001-00011
- The paper
- Kokai, M., Kashiwamura, S.-I., Okamura, H., Ohara, K., & Morita, Y. (2002). Plasma Interleukin-18 Levels in Patients With Psychiatric Disorders. Journal of Immunotherapy. https://doi.org/10.1097/00002371-200203001-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.